Abstract
Objectives: Metastatic melanoma (MM) is a leading cause of years of life lost due to malignancy. This study aimed to identify the average years of life lost (AYLL) in MM patients. Methods: MM patients were identified from a prospectively maintained database, and a linear model predicting AYLL was developed. Results: Between 1970 and 1999, 4,774 patients diagnosed with MM died. The AYLL was 23.2 years. AYLL remained stable across three decades. Conclusions: AYLL for MM is greater than 20 years, and has not improved. This burden underscores the need for continued research and access to funding for this disease.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 637-641 |
| Number of pages | 5 |
| Journal | Cancer Investigation |
| Volume | 30 |
| Issue number | 9 |
| DOIs | |
| State | Published - Nov 1 2012 |
| Externally published | Yes |
Keywords
- Life expectancy
- Melanoma
- Mortality
- Potential years of life lost
- Survival
ASJC Scopus subject areas
- Oncology
- Cancer Research
Fingerprint Dive into the research topics of 'The effect of metastatic site and decade of diagnosis on the individual burden of metastatic melanoma: Contemporary estimates of average years of life lost'. Together they form a unique fingerprint.
Cite this
Salama, A. K. S., Rosa, N. D., Scheri, R. P., Herndon, J. E., Tyler, D. S., Marcello, J., Pruitt, S. K., & Abernethy, A. P. (2012). The effect of metastatic site and decade of diagnosis on the individual burden of metastatic melanoma: Contemporary estimates of average years of life lost. Cancer Investigation, 30(9), 637-641. https://doi.org/10.3109/07357907.2012.726387